Insider Transactions Reported by 12 Insiders of AbCellera Biologics Inc.

Symbol
ABCL on Nasdaq
Location
Vancouver, British Columbia, Canada

Insiders trading volume in the past year

AbCellera Biologics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thermopylae Holdings Ltd. 10%+ Owner $193,101,293 +$711,004 +0.37% 27 Feb 2026
JOHN HAMER Director $39,783,482 31 Aug 2021
Stephen Quake Director $4,005,586 01 Dec 2025
Ester Falconer Chief Technology Officer $2,362,500 23 Sep 2021
Andrew Booth Chief Financial Officer $1,174,453 +$145,692 +14% 27 Feb 2026
John S. Montalbano Director $815,593 +$178,460 +28% 26 Nov 2025
Bio L.P. DCVC 10%+ Owner $199,508 18 Jun 2021
Carl L. G. Hansen Chief Executive Officer, Director, 10%+ Owner 01 Jan 2026
Tryn Stimart Chief Legal Officer 01 Jan 2026
Veronique Lecault Chief Technology Officer, Director 01 Jan 2026
Michael R. Hayden Director 12 Jun 2025
Andrew Lo Director 12 Jun 2025

Recent Insider Transactions by Companies or Individuals for AbCellera Biologics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.